Security key
00461U105
Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)
CUSIP: 00461U105
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, $0.00001 par value
- Shares outstanding
- 138,752,791
- Total 13F shares
- 87,478,919
- Share change
- +36,024,295
- Total reported value
- $216,988,373
- Put/Call ratio
- 42%
- Reported price per share
- $2.48
- Number of holders
- 97
- Value change
- +$93,728,957
- Number of buys
- 54
- Number of sells
- 36
Security identity
Holder snapshot
Report period
Q4 2024
Institutions
97
Top holders
10
ACRS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Aclaris Therapeutics, Inc. SEC filings
Aclaris Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00461U105
Recent filing periods:
Ownership snapshot
Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
BML Capital Management, LLC
13D/G signal
—
Evidence rows
50
Latest as of
30 Sep 2024
Rank 1 holder
BML Capital Management, LLC
13F
- Ownership
- 10%
- Position
- $16.39M
Rank 2 holder
VANGUARD GROUP INC
13F
- Ownership
- 3.4%
- Position
- $5.39M
Rank 3 holder
D. E. Shaw & Co., Inc.
13F
- Ownership
- 2.4%
- Position
- $3.88M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BML Capital Management, LLC |
13F
Company
|
10%
|
$16,387,500
14,250,000 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.4%
|
$5,388,323
4,685,498 shares
|
— | 30 Sep 2024 |
| D. E. Shaw & Co., Inc. |
13F
Company
|
2.4%
|
$3,877,627
3,371,849 shares
|
— | 30 Sep 2024 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
2.2%
|
$3,456,438
3,005,598 shares
|
— | 30 Sep 2024 |
| Rock Springs Capital Management LP |
13F
Company
|
2%
|
$3,166,519
2,753,495 shares
|
— | 30 Sep 2024 |
| Stonepine Capital Management, LLC |
13F
Company
|
1.8%
|
$2,827,704
2,458,873 shares
|
— | 30 Sep 2024 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
1.5%
|
$2,388,000
2,078,287 shares
|
— | 30 Sep 2024 |
| Trium Capital LLP |
13F
Company
|
1.4%
|
$2,200,000
1,912,990 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
97
Shares
87,478,919
Rows loaded
98
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
76
Q4 2024 holders
97
Holder diff
21
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend